Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Sahasrabuddhe, Vikrant V ^a   Bhosale, Ramesh A ^b   Joshi, Smita N ^c   Kavatkar, Anita N ^b   Nagwanshi, Chandraprabha A ^b   Kelkar, Rohini S ^d   Jenkins, Cathy A ^a   Shepherd, Bryan E ^a   Sahay, Seema ^c   Risbud, Arun R ^c   Vermund, Sten H ^a   Mehendale, Sanjay M ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b Byramjee Jeejeebhoy Medical College   (India)

^c NATIONAL AIDS RESEARCH INSTITUTE   (India)

^d TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; MAJOR CLINICAL STUDY; MORBIDITY; SOCIAL ASPECT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; PATHOLOGY; PREVALENCE;

HUMAN PAPILLOMAVIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; INDIA; PREVALENCE;

EID: 77649095695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008634     Document Type: Article

References (47)

1. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
2. Palefsky JM, Holly EA (2003) Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr. pp 41-46.
3. Dhir AA, Sawant SP (2008) Malignancies in HIV: the Indian scenario. Curr Opin Oncol 20: 517-521.
4. UNAIDS (2007) 2007 AIDS Epidemic Update. Joint United Nations Programme on HIV/AIDS.
5. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
6. Over M, Marseille E, Sudhakar K, Gold J, Gupta I, et al. (2006) Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options. Sex Transm Dis 33: S145-152.
7. Franceschi S, Jaffe H (2007) Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 45: 510-513.
8. Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, et al. (2008) Incidence of common opportunistic infections inHIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis.
9. Joshi J, Mali B, Bhave G, Wagle U (1993) Cervical neoplasia and cytological manifestations of sexually transmitted diseases in HIV-seropositive prostitutes. Cytopathology 4: 63-64.
10. Joshi S, Chandorkar A, Krishnan G, Walimbe A, Gangakhedkar R, et al. (2001) Cervical intraepithelial changes & HIV infection in women attending sexually transmitted disease clinics in Pune, India. Indian J Med Res 113: 161-169.
11. Joshi SN, Gopalkrishna V, Kumar BK, Dutta S, Nyaynirgune P, et al. (2005) Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J Med Virol 76: 470-475.
12. Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, et al. (2009) Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India. J Low Genit Tract Dis 13: 159-164.
13. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, et al. (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132: 810-819.
14. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S (2005) A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 89 Suppl 2: S4-S12.
15. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, et al. (2008) European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 19: 342-354.
16. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, et al. (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197: 346-355.
17. World Health Organization (2003) Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: World Health Organization.
18. Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, et al. (2001) Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol 65: 155-162.
19. Sellors JW, Sankaranarayanan R, International Agency for Research on Cancer (2003) Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner's manual. Lyon, France: International Agency for Research on Cancer.
20. Richart RM (1973) Cervical intraepithelial neoplasia. Pathol Annu 8: 301-328.
21. Armstrong BG, Sloan M (1989) Ordinal regression models for epidemiologic data. Am J Epidemiol 129: 191-204.
22. Harrell FE (2001) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer.
23. Harrell FE Jr, Lee KL, Matchar DB, Reichert TA (1985) Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 69: 1071-1077.
24. Dexeus S, Cararach M, Dexeus D (2002) The role of colposcopy in modern gynecology. Eur J Gynaecol Oncol 23: 269-277.
25. Kosinski AS, Barnhart HX (2003) Accounting for nonignorable verification bias in assessment of diagnostic tests. Biometrics 59: 163-171.
26. Heard I, Palefsky JM, Kazatchkine MD (2004) The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 9: 13-22.
27. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, et al. (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. Aids 15: 2157-2164.
28. Hawes SE, Critchlow CW, Sow PS, Toure P, N'Doye I, et al. (2006) Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst 98: 100-109.
29. Denny L, Boa R, Williamson AL, Allan B, Hardie D, et al. (2008) Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 111: 1380-1387.
30. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, et al. (2006) Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022.
31. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, et al. (2008) A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 9: 929-936.
32. Gravitt PE, Coutlee F, Iftner T, Sellors JW, Quint WG, et al. (2008) New technologies in cervical cancer screening. Vaccine 26 Suppl 10: K42-52.
33. Ballagh S (2004) Factors affecting the reproducibility and validity of colposcopy for product development: review of current literature. J Acquir Immune Defic Syndr 37 Suppl 3: S152-155.
34. Massad LS, Schneider M, Watts H, Darragh T, Abulafia O, et al. (2001) Correlating Papanicolaou Smear, Colposcopic Impression, and Biopsy: Results from the Women's Interagency HIV Study. J Low Genit Tract Dis 5: 212-218.
35. McCluggage WG, Bharucha H, Caughley LM, Date A, Hamilton PW, et al. (1996) Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J Clin Pathol 49: 833-835.
36. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUSLSIL Triage Study. JAMA 285: 1500-1505.
37. McCluggage WG, Walsh MY, Thornton CM, Hamilton PW, Date A, et al. (1998) Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol 105: 206-210.
38. Jeronimo J, Schiffman M (2006) Colposcopy at a crossroads. Am J Obstet Gynecol 195: 349-353.
39. Massad LS, Evans CT, Strickler HD, Burk RD, Watts DH, et al. (2005) Outcome after negative colposcopy among human immunodeficiency virusinfected women with borderline cytologic abnormalities. Obstet Gynecol 106: 525-532.
40. Pretorius RG, Bao YP, Belinson JL, Burchette RJ, Smith JS, et al. (2007) Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer 121: 2218-2224.
41. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, et al. (2004) Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 191: 430-434.
42. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, et al. (2006) Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 108: 264-272.
43. Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 5: e132.
44. Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, et al. (2008) Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine 26 Suppl 12: M43-52.
45. Patro BK, Nongkynrih B (2007) Review of screening and preventive strategies for cervical cancer in India. Indian J Public Health 51: 216-221.
46. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP (2008) Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ 86: D-E.
47. Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP (2009) HPV screening for cervical cancer in rural India. N Engl J Med 361: 305; author reply 306.